UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

Lancet neurology, 2014-09, Vol.13 (9), p.885-892

2014

Volltextzugriff (PDF)

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Lancet neurology, 2015-11, Vol.14 (11), p.1091-1100

2015

Volltextzugriff (PDF)

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee

Pain (Amsterdam), 2013-09, Vol.154 (9), p.1603-1612

2013

Volltextzugriff (PDF)

tDCS-Induced Analgesia and Electrical Fields in Pain-Related Neural Networks in Chronic Migraine

Headache, 2012-09, Vol.52 (8), p.1283-1295

2012

Volltextzugriff (PDF)

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review

Pain and therapy, 2023-10, Vol.12 (5), p.1109-1119

2023

Volltextzugriff (PDF)

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Journal of headache and pain, 2021-03, Vol.22 (1), p.16-16, Article 16

2021

Volltextzugriff (PDF)

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study

Headache, 2021-10, Vol.61 (9), p.1376-1386

2021

Volltextzugriff (PDF)

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

Headache, 2019-11, Vol.59 (10), p.1743-1752

2019

Volltextzugriff (PDF)

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Journal of headache and pain, 2021-11, Vol.22 (1), p.143-143, Article 143

2021

Volltextzugriff (PDF)

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study

Pain (Amsterdam), 2016-11, Vol.157 (11), p.2517-2526

2016

Volltextzugriff (PDF)

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes

Annals of surgical oncology, 2015-12, Vol.22 (Suppl 3), p.766-771

2015

Volltextzugriff (PDF)

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1202-1211

2015

Volltextzugriff (PDF)

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

Journal of headache and pain, 2021-04, Vol.22 (1), p.26-26, Article 26

2021

Volltextzugriff (PDF)

Menstrual‐Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study

Pain medicine (Malden, Mass.), 2015-07, Vol.16 (7), p.1426-1432

2015

Volltextzugriff (PDF)

Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes

Pain medicine (Malden, Mass.), 2018-06, Vol.19 (6), p.1184-1194

2018

Volltextzugriff (PDF)

Sufficiency and Necessity in Migraine: How do we Figure Out if Triggers are Absolute or Partial and, if Partial, Additive or Potentiating?

Current pain and headache reports, 2014-10, Vol.18 (10), p.455-455, Article 455

2014

Volltextzugriff (PDF)

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Journal of headache and pain, 2021-05, Vol.22 (1), p.46-46, Article 46

2021

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

Headache, 2015-01, Vol.55 (1), p.88-100

2015

Volltextzugriff (PDF)

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Journal of headache and pain, 2017-12, Vol.18 (1), p.31-8, Article 31

2017

Volltextzugriff (PDF)

Hemicrania Continua Should NOT Be Classified as a Trigeminal Autonomic Cephalalgia

Headache, 2013-05, Vol.53 (5), p.869-870

Spierings, Egilius L. H.

2013

Volltextzugriff (PDF)

A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting Ability

The Clinical journal of pain, 2021-01, Vol.37 (1), p.38-42

2021

Volltextzugriff (PDF)

Intermittent sharp facial pain starting at the mandibular right first molar: A diagnostic challenge

The Journal of the American Dental Association (1939), 2016-03, Vol.147 (3), p.196

2016

Volltextzugriff (PDF)

Precipitating and Aggravating Factors of Migraine Versus Tension-type Headache

Headache, 2001-06, Vol.41 (6), p.554-558

2001

Volltextzugriff (PDF)

Daily Triptan Use for Intractable Migraine

Headache, 2014-01, Vol.54 (1), p.155-162

Spierings, Egilius L.H.

2014

Volltextzugriff (PDF)

Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis

Journal of allergy and clinical immunology, 2008, Vol.121 (1), p.105-109

2008

Volltextzugriff (PDF)

1 – 25 von 343

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(308)
Mit Volltextzugriff
(235)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee

tDCS-Induced Analgesia and Electrical Fields in Pain-Related Neural Networks in Chronic Migraine

Celecoxib Oral Solution and the Benefits of Self-Microemulsifying Drug Delivery Systems (SMEDDS) Technology: A Narrative Review

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes of migraine‐preventive medications in the phase 3b FOCUS study

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

Menstrual‐Cycle and Menstruation Disorders in Episodic vs Chronic Migraine: An Exploratory Study

Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes

Sufficiency and Necessity in Migraine: How do we Figure Out if Triggers are Absolute or Partial and, if Partial, Additive or Potentiating?

Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine

Hemicrania Continua Should NOT Be Classified as a Trigeminal Autonomic Cephalalgia

A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting Ability

Intermittent sharp facial pain starting at the mandibular right first molar: A diagnostic challenge

Precipitating and Aggravating Factors of Migraine Versus Tension-type Headache

Daily Triptan Use for Intractable Migraine

Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis

Suchergebnisse filtern